Huxley Medical Launches First-of-Its-Kind SANSA Home Sleep Apnea Test

Huxley Medical has announced SANSA device for chest-worn, sleep apnea diagnostic patch. The patch is a first-of-its-kind, at-home diagnostic device designed for single-point skin contact, marking a significant advancement in medical technology.

Unlike other patches SANSA does not require additional attachments, wires, belts, or tubes. Its unique combination of sensors and materials accurately tracks eight physiological parameters: blood oxygen levels, heart rate derived from EKG, respiratory effort, chest movement, sleep stages, snoring, body position, and actigraphy.

SANSA device gives advanced signal processing and artificial intelligence to detect sleep disordered breathing while simultaneously providing an electrocardiogram (EKG) reference channel to record electrical signals from the heart.

SANSA has shown certain measurement capabilities and performance in diagnosing sleep apnea, whether mild, moderate, or severe.

The clinical trial gives the data that underscores SANSA's safety and effectiveness, including:

• High accuracy, sensitivity, and specificity in detecting sleep apnea when compared to traditional in-lab sleep tests.
• Enhanced patient compliance and comfort to its non-invasive approach.
• Outstanding performance across various skin tones, facilitating better management of diverse patient population.

SANSA device has the ability to diagnose sleep apnea represents an exciting opportunity to manage two diseases that often co-exist, called atrial fibrillation and sleep apnea.

SANSA device provides obstructive sleep apnea at all severity levels with reliable performance across all skin tones. This 8-channel wearable patch, including an EKG sensor, is easy for patient self-application and improved the experience for diagnosis of obstructive sleep apnea.

Source: https://www.prnewswire.com/news-releases/us-food-and-drug-administration-gives-huxley-medical-510k-clearance-for-sansa-home-sleep-apnea-test-302216001.html